December 18, 2017

December 15, 2017

Subscribe to Latest Legal News and Analysis

Three Questions You Need to Ask When Negotiating Digital Health Deals

According to a distinguished panel of lawyers, companies involved in Digital Health deals need to ask themselves the following questions:

  • What data is required to develop and deliver the Digital Health solution, and does your company have sufficient expertise in-house to analyze the data?
  • What happens if your technology vendor becomes unable or unwilling to support or further develop software used in your Digital Health solution?
  • How do you structure a contract to develop and deliver a Digital Health service when the ultimate composition of the service, the customer base, and reimbursement model are all uncertain at the outset?

David Boyko, Division Counsel for MSD’s Healthcare Services and Solutions, and Nigel Howard, Daniel Pavin, and David Wildman of Covington addressed these key issues in an October 10, 2017 webinar on “Commercial and IT issues in Digital Health Deals.” This is the first of a series of webinars Covington is offering to help companies navigate the laws, regulations, and policies that govern the evolving Digital Health sector. These webinars are aimed at:

  • Legal and business teams involved in structuring and negotiating arrangements in the digital health space.
  • Legal and business teams with a background in “traditional” pharma-biotech collaborations who are looking to move into the digital health space.

 

  

© 2017 Covington & Burling LLP

TRENDING LEGAL ANALYSIS


About this Author

Elizabeth Guo, Liz Guo, Covington, Washington, DC, Associate, public policy, FDA, DEA, pharmaceuticals, regulatory
Associate

Elizabeth Guo advises clients on regulatory, compliance, and policy matters affecting pharmaceuticals, biological products, medical devices, digital health products and services, cosmetics, and dietary supplements. She counsels clients on compliance and interactions with state and federal regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA). Ms. Guo regularly assists clients with drafting legislation as well as preparing public comments for agency rulemaking. She also provides advice and regulatory due...

202-662-5852